Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome

Journal of Immunology

Volumn 167, Issue 10, 2001, Pages 6031-6037

  Ishimaru, N ^a   Yanagi, K ^a   Ogawa, K ^a   Suda, T ^a   Saito, I ^a   Hayashi, Y ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; FAS ANTIGEN; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL DEATH; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; EFFECTOR CELL; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION; SJOEGREN SYNDROME; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

EID: 0035889899     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.10.6031     Document Type: Article

References (51)

1. Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family
2. The Fas death factor
3. Autocrine T cell suicide mediated by Apo-1/(Fas/CD95)
4. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
5. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
6. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
7. Peripheral deletion of antigen-reactive T cells in oral tolerance
8. Apoptosis in the pathogenesis and treatment of disease
9. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
10. Fas and Fas ligand: lpr and gld mutations
11. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
12. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr
13. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide
14. Virus, cytokine, antigens, and autoimmunity
15. Rheumatoid arthritis
16. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen
17. Diagnostic criteria and immunopathogenesis of Sjögren's syndrome: Implications for therapy
18. Identification of α fodrin as a candidate autoantigen in primary Sjögren's syndrome
19. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis
20. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
21. Murine autoimmune disease due to integration of an endogenous retrovirus in an apoptosis gene
22. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice
23. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retro-transposon, ETn
24. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
25. Matrix metalloproteinases in immunity
26. Regulation of cell surface APO-1/Fas(CD95) ligand expression by metalloproteases
27. T cell gelatinases mediate basement membrane transmigration in vitro
28. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent
29. Metalloproteinase-mediated release of human Fas ligand
30. Processing of tumor necrosis factor-α precursor by metalloproteinases
31. A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice
32. Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease
33. A new mutation involving the sublingual gland in NFS/N mice: Partially arrested mucous cell differentiation
34. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice
35. Induction of experimental autoallergic sialadenitis
36. Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10
37. Massive upregulation of the Fas ligand in lpr and gld mice: Implications for Fas regulation and the graft-versus-host disease-like wasting syndrome
38. The role of Fas in autoimmune diabetes
39. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice
40. + encephalitogenic T cells
41. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: Further evidence of apoptotic deletion of autoreactive T cells in the central nervous system
42. Antigen- induced death of mature T lymphocytes: Analysis by flow cytometry
43. + T lymphocytes
44. + T-cell clones presenting and simultaneously responding to an antigen die of apoptosis
45. Two mechanisms of antigen-specific apoptosis of myelin basic protein-specific T lymphocytes derived from multiple sclerosis patients and normal individuals
46. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells
47. Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins
48. Peripheral tolerance in T cell receptor-transgenic mice: Evidence for T cell anergy
49. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
50. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity
51. Downregulation of Fas ligand by shedding